QA: Celldex Therapeutics Inc. in us_medicinal_products/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000744218_2020_Celldex_Therapeutics_Inc.pdf

Logs

info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'}

Graph

Absolute values for 0000744218, Celldex Therapeutics Inc.

  xvar xval
0 LiabilitiesNoncurrent 17,264,000
1 LiabilitiesCurrent 11,643,000
2 remainder_Liabilities 0
3 AssetsCurrent 66,698,000
4 AssetsNoncurrent 3,514,000
5 PropertyPlantAndEquipmentNet 4,031,000
6 Goodwill 48,690,000
7 remainder_Assets 0
8 GeneralAndAdministrativeExpense 15,426,000
9 ResearchAndDevelopmentExpense 42,672,000
10 remainder_Expenses 506,000
11 remainder_Revenues 7,726,000
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 36,000
  yvar yval
0 Liabilities 28,907,000
1 Assets 122,933,000
2 Expenses 58,604,000
3 Revenues 7,726,000
4 StockholdersEquity 94,026,000
5 NetIncome -50,878,000
6 ComprehensiveNetIncome -50,860,000
7 BaseVar 109,103,000
8 EconomicCapitalRatio 0.383

Edgar->Model Mapping

Feature Distribution

Change over Time